Kite Analysis: $17M Raised
What is Kite?
Kite develops innovative video solutions for businesses, enhancing communication and collaboration through advanced video technology and tools.
Founded
2022
Company Stage
Series B
YC Batch
S23
Product Features & Capabilities
- Chimeric Antigen Receptor (CAR) T-cell therapy, engineered autologous T cells, treatment for Diffuse Large B-cell Lymphoma (DLBCL), primary mediastinal B-cell lymphoma (PMBCL), transformed follicular lymphoma (TFL), and Mantle Cell Lymphoma (MCL).
How much Kite raised
Series A - Raised:** $17 million
Announced:** January 28, 2019Lead Investor: - Trinity Ventures
Investors
- Arie Belldegrun
- Bellco Capital
- InterWest Partners
- Alta Partners
- BB Biotech
